Yeast Infection Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Yeast Infection Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Therapeutic Area

Report Description


Yeast infection, also known as candiasis, is a common fungal infection. Yeast infection generally occurs in the private parts of the human body and on the skin; however, it can also occur in the intestine, oral cavity, and other parts of the body. Vaginal yeast infection is a common fungal infection and is called candidal vaginitis or candidal vulvovaginitis (CVV). It is usually caused by a yeast named candida albicans. A healthy vagina normally has a number of bacteria and yeast cells. A common bacteria named lactobacillus acidophilus found in the vagina prevents the yeast cells from growing abnormally; however, sometimes due to certain factors, such as prolonged usage of antibiotics, compromised immunity, or lack of hygiene, can develop candida and cause yeast infection. Symptoms of vaginal yeast infection include itching, burning sensation or pain during urination or sexual intercourse, swelling, rashes, and redness. Earlier, yeast infections were not common and systemic or serious yeast infection were rare. But with the advent of broad-spectrum antibiotics and their widespread usage, prevalence of yeast infections is rising rapidly. Such antibiotics, in conjunction with killing pathogenic bacteria, also decrease or eliminate healthy and non-pathogenic bacteria that keeps fungal infection under check. This phenomenon can be particularly fatal in patients with acquired immunodeficiency syndrome, HIV, or cancer. An opportunistic infection such as yeast or other fungal infection in such patients can cause a number of complications.

The global yeast infection treatment market is anticipated to expand at a significant rate during the forecast period owing to a multitude of factors. Rapidly increasing and unrestrained usage of antibiotics leading to high prevalence of yeast infection is expected to augment the demand for yeast infection treatment drugs globally. Moreover, increase in the global burden of various ailments such as cardiovascular, neurological, and gastrointestinal diseases as well as cancer has boosted the consumption of broad-spectrum antibiotics, thereby propelling the number of yeast infection cases. Rapid increase in the global disease burden, coupled with escalating demand for better treatment options and increasing number of hospital-acquired infections, is also promoting the demand for yeast infection treatment. Other factors driving the global yeast infection treatment market are development of novel anti-fungal drugs, increase in health care expenditure, and development in health care infrastructure.

The global yeast infection treatment market can be segmented based on treatment type, pathogen, infection type, end-user, and region. In terms of treatment type, the yeast infection treatment market can be classified into oral medication, creams/ointments and suppositories, probiotics, and surgery. On the basis of pathogen, the yeast infection treatment market can be categorized into candida albicans, candida glabrata, candida rugosa, and others. In terms of infection type, the yeast infection treatment market can be divided into vaginal infection, skin infection, throat infection, and others. Based on end-user, the yeast infection treatment market can be classified into hospitals, clinics, pharmacies, and others. In terms of region, the global yeast infection treatment market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is anticipated to account for a dominant share of the global yeast infection treatment market due to rise in the number of urology patients, presence of superior health care infrastructure, and favorable reimbursement scenario in the region. The yeast infection treatment market in Europe is also expected to expand rapidly due to growth of geriatric population and high number of surgical procedures in the region. The yeast infection treatment market in Asia Pacific is expected to expand significantly during the forecast period. Rise in population and rapidly developing health care sector in the emerging economies in Asia Pacific are anticipated to augment the yeast infection treatment market in the region during the forecast period.

Key players operating in the global yeast infection treatment market include Astellas, Merck & Co., Inc., Abbott laboratories, Synmedic Laboratories, Sanofi, Astra Zeneca, Novartis, Allergan, and Pfizer.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients